Titre :
  • Management of aromatase inhibitor-associated bone loss in postmenopausal women with breast cancer: practical guidance for prevention and treatment.
Auteur : Hadji, Peyman ; Aapro, M.S. ; Body, Jean-Jacques ; Bundred, N J ; Brufsky, Adam ; Coleman, Rosemary ; Gnant, Michael ; Guise, Theresa ; Lipton, Allan
Informations sur la publication : Annals of oncology, 22, 12, (page 2546-2555)
Statut de publication : Publié, 2011-12
Sujet CREF : Sciences bio-médicales et agricoles
Mots-clés : Aromatase inhibitor
Bisphosphonate
Bone loss
Breast cancer
Fracture risk
Zoledronic acid
Mots-clés MeSH : Antineoplastic Agents -- adverse effects -- therapeutic use
Aromatase Inhibitors -- adverse effects -- therapeutic use
Bone Density Conservation Agents -- therapeutic use
Breast Neoplasms -- drug therapy
Diphosphonates -- therapeutic use
Female
Humans
Imidazoles
Osteoporosis, Postmenopausal -- chemically induced -- prevention & control
Practice Guidelines as Topic
Randomized Controlled Trials as Topic
Risk Factors
Note : Journal Article
Research Support, Non-U.S. Gov't
Review
SCOPUS: re.j
Langue :
  • Anglais
Identificateurs : urn:issn:0923-7534 
info:doi/10.1093/annonc/mdr017
info:pii/mdr017
info:pmid/21415233